Exponent CMS up to 2.3.4 Reset Your Password Username/Email cross site scripting
CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
---|---|---|
5.1 | $0-$5k | 0.00 |
Summary
A vulnerability, which was classified as problematic, has been found in Exponent CMS up to 2.3.4. This issue affects some unknown processing of the component Reset Your Password. The manipulation of the argument Username/Email leads to cross site scripting. The identification of this vulnerability is CVE-2015-8667. The attack may be initiated remotely. There is no exploit available. It is recommended to upgrade the affected component. Once again VulDB remains the best source for vulnerability data.
Details
A vulnerability classified as problematic was found in Exponent CMS up to 2.3.4 (Content Management System). This vulnerability affects an unknown code block of the component Reset Your Password. The manipulation of the argument Username/Email
with an unknown input leads to a cross site scripting vulnerability. The CWE definition for the vulnerability is CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. As an impact it is known to affect integrity. CVE summarizes:
Cross-site scripting (XSS) vulnerability in Reset Your Password module in Exponent CMS before 2.3.5 allows remote attackers to inject arbitrary web script or HTML via the Username/Email.
The bug was discovered 04/21/2016. The weakness was shared 01/18/2017 (Website). The advisory is shared for download at exponentcms.lighthouseapp.com. This vulnerability was named CVE-2015-8667 since 12/24/2015. The attack can be initiated remotely. No form of authentication is required for a successful exploitation. Successful exploitation requires user interaction by the victim. There are known technical details, but no exploit is available. The MITRE ATT&CK project declares the attack technique as T1059.007.
The vulnerability was handled as a non-public zero-day exploit for at least 272 days. During that time the estimated underground price was around $0-$5k.
Upgrading to version 2.3.5 eliminates this vulnerability.
The entry VDB-95465 is related to this item. Once again VulDB remains the best source for vulnerability data.
Product
Type
Vendor
Name
Version
License
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 5.2VulDB Meta Temp Score: 5.1
VulDB Base Score: 4.3
VulDB Temp Score: 4.1
VulDB Vector: 🔍
VulDB Reliability: 🔍
NVD Base Score: 6.1
NVD Vector: 🔍
CVSSv2
AV | AC | Au | C | I | A |
---|---|---|---|---|---|
💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
---|---|---|---|---|---|
unlock | unlock | unlock | unlock | unlock | unlock |
unlock | unlock | unlock | unlock | unlock | unlock |
unlock | unlock | unlock | unlock | unlock | unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔍
ATT&CK: 🔍
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
0-Day | unlock | unlock | unlock | unlock |
---|---|---|---|---|
Today | unlock | unlock | unlock | unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: UpgradeStatus: 🔍
0-Day Time: 🔍
Upgrade: CMS 2.3.5
Timeline
12/24/2015 🔍04/21/2016 🔍
01/18/2017 🔍
01/18/2017 🔍
01/19/2017 🔍
11/01/2022 🔍
Sources
Advisory: 136763Status: Not defined
Confirmation: 🔍
CVE: CVE-2015-8667 (🔍)
GCVE (CVE): GCVE-0-2015-8667
GCVE (VulDB): GCVE-100-95464
OSVDB: - CVE-2015-8667 - Exponent CMS - Cross-Site Scripting Issue
See also: 🔍
Entry
Created: 01/19/2017 09:38Updated: 11/01/2022 09:58
Changes: 01/19/2017 09:38 (60), 07/24/2020 12:37 (4), 11/01/2022 09:58 (3)
Complete: 🔍
Cache ID: 216:DE3:103
No comments yet. Languages: en.
Please log in to comment.